Tyson Fetzer
About Tyson Fetzer
Tyson Fetzer serves as the Sr. Director of Supply Chain and Manufacturing at Generate Biomedicines, bringing extensive experience from previous roles at Rubius Therapeutics, Sanofi Genzyme, and Baxter International.
Current Role at Generate Biomedicines
Tyson Fetzer serves as the Sr. Director of Supply Chain and Manufacturing at Generate Biomedicines. He has held this position since 2022, contributing to the company's operations in Cambridge, Massachusetts. In this role, he oversees supply chain strategies and manufacturing processes, ensuring efficient production and distribution of biomedicines.
Previous Experience at Rubius Therapeutics
Prior to his current role, Tyson Fetzer worked at Rubius Therapeutics in various capacities. He was the Director and Head of Manufacturing from 2018 to 2020, and later served as the Sr. Director, Head of Supply Chain and External Manufacturing from 2021 to 2022. His tenure at Rubius Therapeutics spanned over three years, during which he focused on supply chain management and manufacturing operations in Cambridge, Massachusetts.
Experience at Sanofi Genzyme
Tyson Fetzer has significant experience at Sanofi Genzyme, where he held multiple roles. He served as the Associate Director of Manufacturing Operations from 2017 to 2018 and as the Sr. Manager of Manufacturing Operations from 2015 to 2017. Both positions were based at the Allston Landing Facility, where he contributed to the manufacturing processes and operational efficiency.
Background in Manufacturing at Baxter International Inc.
Tyson Fetzer began his career at Baxter International Inc., where he held several positions. He worked as a Manufacturing Supervisor II from 2013 to 2015 in Los Angeles, California, and as an Operations Development Program Associate from 2011 to 2013 in Westlake Village, California. His roles involved overseeing manufacturing operations and participating in development programs.
Educational Qualifications
Tyson Fetzer holds a Master of Bioscience degree from Keck Graduate Institute, where he studied the Business of Bioscience from 2009 to 2011. He also earned a Bachelor of Science in Biology with a minor in Business Administration from Texas A&M University, completing his studies from 2004 to 2008. His educational background supports his expertise in the bioscience and manufacturing sectors.